Back to Results
First PageMeta Content
Radiofrequency ablation / Surgical oncology / Eli Lilly and Company / Oncology / Pancreatic cancer / Gemcitabine / Medicine / Interventional radiology / Surgical specialties


PELICAN trial Pancreatic Locally advanced Irresectable Cancer Ablation in the Netherlands: A randomized controlled superiority phase III multicenter trial A study of the Dutch Pancreatic Cancer Group: Protocol committee
Add to Reading List

Document Date: 2015-03-25 05:24:15


Open Document

File Size: 1,08 MB

Share Result on Facebook

City

Verona / /

Company

Pancreatic Cancer Group / Dutch Pancreatic Cancer Group / Cox / IKNL / /

Country

Netherlands / /

/

Event

FDA Phase / /

Facility

University Medical Center Dept / University Medical Center Utrecht Dept / Jeroen Bosch Hospital / the Netherlands Cancer Institute / Surgery G4-196 Academic Medical Center / St. Antonius Hospital / University Medical Center Utrecht Dept. / University Medical Center Utrecht Department / Surgery Academic Medical Center / Catharina Hospital / Academic Medical Center / VU University Medical Center / /

MedicalCondition

metastatic disease / local tumor / locally irresectable disease / Pancreatic cancer / tumor / Cancer / tumors / disease / pain / General introduction Pancreatic cancer / radiological tumor / distant metastases / /

MedicalTreatment

radiation therapy / Chemotherapy / Surgery / Investigational treatment / /

Organization

VU University Medical Center Amsterdam / St. Antonius Hospital / Radboud University Medical Center / Santvoort Department / the Netherlands Cancer Institute / Surgery G4-196 Academic Medical Center Amsterdam / Surgery Academic Medical Center Amsterdam / Department of Surgery Division / Tanis Department / Jeroen Bosch Hospital / Department of Surgery / Protocol committee / Catharina Hospital / /

Person

Porte / Besselink / Q.Molenaar / van Goor / van Hillegersberg / Stommel / Girelli / Busch / Kazemier / Meijerink / Festen / Boerma / Borel Rinkes / Bassi / N. Haj Mohammad / Antoni van Leeuwenhoek / Klaase / van Dam / van Santvoort / de Hingh / van den Bosch / van Laarhoven / Bosscha / Patijn / de Jong / van der Tweel / Dejong / L.Schultze Kool / Steffi Rombouts / /

/

Position

project leader / statistician / Amsterdam Correspondence study coordinator / General / Background and rationale 1.1 General / D.A. Legemate Head / Surgery University Medical Center Utrecht h.vansantvoort@umcutrecht.nl Coordinating investigator / head of mmunology research Drs SJE Rombouts / surgeon / local principal investigator / /

Product

MG Besselink2 / fluorouracil / Rombouts1 / /

Technology

radiation / medical oncologist Protocol / surgeon Protocol / 40 Protocol / monotherapy 25 Protocol / study design Protocol / Chemotherapy / s.j.e.rombouts@umcutrecht.nl Protocol / /

URL

www.dpcg.nl / /

SocialTag